Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
icrucumab (IMC-18F1)
i
Other names:
IMC-18F1, LY 3012212
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Eli Lilly
Drug class:
VEGFR inhibitor
Related drugs:
‹
sunitinib (139)
lenvatinib (90)
axitinib (34)
fruquintinib (24)
cediranib (9)
TKI258 (9)
surufatinib (7)
MGCD265 (4)
E 3810 (4)
OMP-305B83 (3)
ABT-869 (2)
DC101 (1)
vorolanib (1)
CS 2164 (1)
KD019 (1)
BMS690514 (0)
CVX-241 (0)
ESK981 (0)
adAptVEGF-C adenoviral vector (0)
SU 14813 (0)
SYHA1813 (0)
VEGFR1-1084 (0)
ABT-165 (0)
ABT348 (0)
PI-88 (0)
SU5416 (0)
GS 6624 (0)
BAY 57- 9352 (0)
RG7221 (0)
PTK787 (0)
sunitinib (139)
lenvatinib (90)
axitinib (34)
fruquintinib (24)
cediranib (9)
TKI258 (9)
surufatinib (7)
MGCD265 (4)
E 3810 (4)
OMP-305B83 (3)
ABT-869 (2)
DC101 (1)
vorolanib (1)
CS 2164 (1)
KD019 (1)
BMS690514 (0)
CVX-241 (0)
ESK981 (0)
adAptVEGF-C adenoviral vector (0)
SU 14813 (0)
SYHA1813 (0)
VEGFR1-1084 (0)
ABT-165 (0)
ABT348 (0)
PI-88 (0)
SU5416 (0)
GS 6624 (0)
BAY 57- 9352 (0)
RG7221 (0)
PTK787 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login